Ruvolo and colleagues also evaluated DFI in 53 men with hypogonadotropic hypogonadism and idiopathic oligoasthenoteratozoospermia before and after 90 days of r-FSH administration. This evidence concerns the gene BRD2 and hypogonadotropic hypogonadism.